Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions

  • Sneha Pandya
  • , Ulrike W Kaunzner
  • , Sandra Milena Hurtado Rua
  • , Nancy Nealon
  • , Jai Perumal
  • , Timothy Vartanian
  • , Thanh D. Nguyen
  • , Susan A Gauthier

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

BACKGROUND AND PURPOSE: To examine the impact of lesion location on longitudinal myelin water fraction (MWF) changes in chronic multiple sclerosis (MS) lesions. Relative hypoxia, due to vascular watershed regions of the cerebrum, has been implicated in lesion development but impact on ongoing demyelination is unknown. METHODS: Forty-eight patients with relapsing-remitting and secondary progressive MS had two MWF scans with fast acquisition, spiral trajectory, and T2prep (FAST-T2) sequence, at an interval of 2.0 (±.3) years. Lesion location was identified based upon cerebral lobe and relation to the ventricles. Change in MWF was assessed using a mixed effects model, controlling for lesion location and patient covariates. RESULTS: Average age was 42.3 (±12) years, mean disease duration was 9.7 (±9.1) years, and median Expanded Disability Status Score (EDSS) was 2.5 (±2.3). The majority of 512 chronic lesions was located in the frontal and parietal lobes (75.6%) and more often periventricular (44.7%). All occipital lesions were periventricular. The average lesion MWF decreased from baseline (.07 ±.03) to 2 years (.06 ±.03) P <.01. Lesions within the occipital lobe showed a significant reduction in MWF as compared to other lobes. CONCLUSIONS: Chronic lesions in the occipital lobe showed the greatest reduction in MWF. Neuroanatomical localization of lesions to the occipital horns of the lateral ventricles, a watershed region, may contribute to ongoing demyelination in this lesion type.
Original languageEnglish
Pages (from-to)537-543
Number of pages7
JournalJournal of Neuroimaging
Volume30
Issue number4
DOIs
StatePublished - Jul 1 2020

Keywords

  • Biomarker
  • MRI
  • T2-Lesions
  • demyelination
  • multiple sclerosis

Cite this